LZL. F. Ziganshina

L. F. Ziganshina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


L. F. Ziganshina has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Experience in Using 99mTc-Technephyt Esophageal Transit Scintigraphy for Assessing Pneumatic Dilation Outcome in Patients with Achalasia Cardia

    by R. A. Bashirov, A. I. Shelepova, L. E. Samoilenko, S. A. Ryzhkin, B. M. Sharafutdinov, A. F. Yusupova, L. F. Ziganshina, B. A. Magomedov, A. I. Kukushkin, V. Yu. Matveev, et al.

    Objective: to show the possibility of using 99mTc-technephyt esophageal transit scintigraphy (ETS) to assess the effect of cardiodilation in patients with achalasia cardia.Material and methods. We examined 7 patients (6 males and 1 female) aged 44–73 years (mean age 57.8 years) diagnosed with achalasia cardia, who were treated in Department of Thoracic Surgery No. 2 at Republican Clinical Hospital from June 2022 to January 2023. The disease duration before admission to the hospital ranged from 2 to 17 years (mean 9.2 years).Results. The analysis of ETS results showed a decreased radiopharmaceutical residual activity percentage in cardia for all patients after treatment compared with the initial data. It indicated a positive effect of cardiodilation and coincided with X-ray examination data. The obtained results demonstrate the possibility of ETS using and its practical significance to assess the effect of therapeutic measures, in particular cardiodilation, in patients with achalasia cardia.Conclusion. Performed according to the described protocol, ETS is a physiological and safe method for both the diagnosis of achalasia and the subsequent assessing therapeutic effect, including cardiodilation, myotomy, conservative treatment, and long-term dynamic monitoring. It is a physiological and safe procedure, which can be recommended in cases of difficulties in evaluating the esophageal function by X-ray, endoscopic and manometric methods or when their use is impossibile.

  • Open Access

    Radionuclide Diagnosis of Esophageal Dysmotility and Gastroesophageal Reflux in Patients with Systemic Sclerosis

    by R. A. Bashirov, L. E. Samoilenko, S. A. Ryzhkin, K. F. Vartanyan, D. A. Gimaletdinova, A. F. Yusupova, D. I. Abdulganieva, L. F. Ziganshina, E. S. Zamanova, E. V. Puzakin, et al.

    Objective: to evaluate the possibilities of dynamic scintigraphy for the diagnosis of esophageal dysmotility (ED) and gastroesophageal reflux (GER) in patients with systemic sclerosis (SS).Material and methods. The study group included 77 patients with established SS of different disease duration (from several months to 30 years) who underwent Technephyt 99mTc dynamic esophageal scintigraphy using two-stage protocol. During the first stage, the esophageal transport function was evaluated; during the second stage, the presence and severity of GER were assessed. Scans were analyzed using visual assessment, quantitative estimation of time/activity curves, and a proposed three-point scale for evaluating ED and GER severity. The control group consisted of 19 practically healthy individuals who underwent a routine examination to exclude digestive system and gastrointestinal tract diseases, the algorithm of which included dynamic scintigraphy.Results. ED was found in 74 of 77 patients (96%). According to three-point scale, severe ED (3 points) was registrated in 41 (55%) patients, moderate ED (2 points) in 15 (21%), and mild ED in 18 (24%). GER was diagnosed in 35 of 77 cases (45%): mild GER in 13 (37%), moderate GER (2 points) in 22 (63%), and none of the patients was found to have severe GER (3 points). A significant relationship between the presence of GER and the severity of ED was not obtained, but a direct correlation was established between ED and GER severity.Conclusion. Most SS patients demonstrated ED of varying severity associated with mild and moderate GER in nearly 45% of the cases. The study results confirm the practical significance of dynamic scintigraphy for assessing the esophageal transport function and GER in SS patients.